29
Views
1
CrossRef citations to date
0
Altmetric
Miscellaneous

Novel urea-based CCR2B receptor antagonists

Pages 115-118 | Published online: 02 Mar 2005

Bibliography

  • TERAN LM: CCL Chemokines and asthma. Immunol Today (2000) 21:235–242.
  • ••Excellent review article.
  • PAAVOLA CD, HEMMERICH S, GRUNBERGER D et al: Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. J. Biol. Chem. (1998) 273(50): 33157–33165.
  • REAPE TJ, GROOT PH: Chemokines and atherosclerosis. Atherosclerosis (1999) 147(2):213–225.
  • MIRZADEGAN T, DIEHL F, EBI B et al: Identification of the binding site for a novel class of CCR2B chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle. J. Biol. Chem. (2000) 275(33):25562–25571.
  • WITHERINGTON J, BORDAS V, COOPER DG et al.: Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonists. Bioorg. Med. Chem. Lett. (2001) 11(16):2177–2180.
  • TARBY CM, ENDO N, MOREE WJ et al: Diamine derivatives as novel antagonists for the CCR2B receptor. 218th ACS Meeting. New Orleans, USA (1999) MEDI082.
  • NO AUTHORS LISTED: Selective CCR2B receptor antagonists based on indole-2-carboxylic acid. Expert Opin. Ther Patents (2001) 11(1):145–148.
  • GLABINSKI AR, RANSOHOFF PM: Targeting the chemokine system for multiple sclerosis treatment. Curt: Opin. Investig. Drugs (2001) 2(12):1712–1719.

Websites

  • http://www.anormed.com/documents/ facts &figures_chemokine.pdf
  • http://www.telik.com/NewFiles/ pipeline.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.